158 related articles for article (PubMed ID: 18431360)
1. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.
Ely A; Naidoo T; Mufamadi S; Crowther C; Arbuthnot P
Mol Ther; 2008 Jun; 16(6):1105-12. PubMed ID: 18431360
[TBL] [Abstract][Full Text] [Related]
2. Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles.
Ely A; Naidoo T; Arbuthnot P
Nucleic Acids Res; 2009 Jul; 37(13):e91. PubMed ID: 19474340
[TBL] [Abstract][Full Text] [Related]
3. tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAs.
Dyer V; Ely A; Bloom K; Weinberg M; Arbuthnot P
Biochem Biophys Res Commun; 2010 Aug; 398(4):640-6. PubMed ID: 20599752
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter.
Mowa MB; Crowther C; Ely A; Arbuthnot P
Biomed Res Int; 2014; 2014():718743. PubMed ID: 25003129
[TBL] [Abstract][Full Text] [Related]
5. Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.
Mowa MB; Crowther C; Ely A; Arbuthnot P
Microrna; 2012; 1(1):19-25. PubMed ID: 25048086
[TBL] [Abstract][Full Text] [Related]
6. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.
Carmona S; Ely A; Crowther C; Moolla N; Salazar FH; Marion PL; Ferry N; Weinberg MS; Arbuthnot P
Mol Ther; 2006 Feb; 13(2):411-21. PubMed ID: 16337206
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.
Chattopadhyay S; Ely A; Bloom K; Weinberg MS; Arbuthnot P
Biochem Biophys Res Commun; 2009 Nov; 389(3):484-9. PubMed ID: 19733548
[TBL] [Abstract][Full Text] [Related]
8. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
Bourhill T; Arbuthnot P; Ely A
J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA.
Ren XR; Zhou LJ; Luo GB; Lin B; Xu A
J Viral Hepat; 2005 May; 12(3):236-42. PubMed ID: 15850463
[TBL] [Abstract][Full Text] [Related]
10. Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs.
Maepa MB; Ely A; Grayson W; Arbuthnot P
Mol Ther Nucleic Acids; 2017 Jun; 7():190-199. PubMed ID: 28624194
[TBL] [Abstract][Full Text] [Related]
11. Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors.
van den Berg FT; Ely A; Arbuthnot P
Methods Mol Biol; 2020; 2115():185-197. PubMed ID: 32006402
[TBL] [Abstract][Full Text] [Related]
12. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes.
Crowther C; Mowa MB; Ely A; Arbuthnot PB
Antivir Ther; 2014; 19(4):363-73. PubMed ID: 24296696
[TBL] [Abstract][Full Text] [Related]
14. [Application of PCR-based tRNAval Pol III-shRNA expression cassettes in screening of efficient siRNA for inhibiting hepatitis B virus].
Pan XC; Chen Z; Ni Q; Yang ZG; Xu N; Jin HY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):154-60. PubMed ID: 16610081
[TBL] [Abstract][Full Text] [Related]
15. Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.
Kumar M; Sharma Y; Bandi S; Gupta S
J Med Virol; 2015 Jul; 87(7):1168-83. PubMed ID: 25690916
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA.
Weinberg MS; Ely A; Barichievy S; Crowther C; Mufamadi S; Carmona S; Arbuthnot P
Mol Ther; 2007 Mar; 15(3):534-41. PubMed ID: 17213835
[TBL] [Abstract][Full Text] [Related]
17. The gRNA-miRNA-gRNA Ternary Cassette Combining CRISPR/Cas9 with RNAi Approach Strongly Inhibits Hepatitis B Virus Replication.
Wang J; Chen R; Zhang R; Ding S; Zhang T; Yuan Q; Guan G; Chen X; Zhang T; Zhuang H; Nunes F; Block T; Liu S; Duan Z; Xia N; Xu Z; Lu F
Theranostics; 2017; 7(12):3090-3105. PubMed ID: 28839466
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
[TBL] [Abstract][Full Text] [Related]
19. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
Arbuthnot P; Carmona S; Ely A
Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
